news aktuell GmbH

Hyundai Motor Group Reveal Mobile Eccentric Droid (MobED) – an All-New Mobility Platform for Versatile Applications

Del

Hyundai Motor Group (the Group) revealed the Mobile Eccentric Droid (MobED), an all-new and pioneering small mobility platform using cutting-edge robotics technologies.

(Eschborn, Germany): The MobED has an innovative design arrangement. It’s flat, rectangular body rides on four large wheels, with an independent suspension that enables optimal body posture and stable movement even on inclined and uneven roads. This suspension allows the platform to move through complex urban environments by freely adjusting its wheelbase and steering angles.

“We have developed the MobED platform to overcome the limitations of existing indoor guide and service robots while maximizing its usability in cities by dramatically improving the platform’s overall mobility,” said Dong Jin Hyun, Head of Hyundai Motor Group Robotics Lab. “We are also looking ahead to assess how potential users of MobED will further expand their needs and use for this type of technology.”

By being equipped with innovative technologies including an advanced ‘Eccentric Wheel’ drive and high-tech steering, braking and altitude control systems, the MobED adapts and realizes optimum posture on various road surfaces and environments. The three motors mounted to each wheel provide power and precise steering to the wheels while also controlling the overall posture of the body.

The intelligent design arrangement of each wheel featuring an individual power and steering control system enables in-place rotation and omnidirectional movement, which allows for highly effective mobility even in narrow situations. The eccentric mechanism-based posture control system also stabilizes the body attitude by adjusting the height of each wheel according to the ground environment. The MobED’s 12-inch pneumatic tires further help to absorb bumps and vibrations.

MobED measures 67 cm long, 60 cm wide, 33 cm high, and weighs 50 kg. Its wheelbase expands to 65 cm for optimum stability in high-speed driving and then scales down to 45 cm for low-speed maneuvers in more complex environments. Its maximum speed is 30 km/h, allowing for around four hours of driving on a single charge with a battery capacity of 2 kWh.

Designed for full versatility and modularity, the MobED can be utilized for various applications, depending on the mounted device. The Group expects the platform’s wheel adjustability, compact body size and low vibration capabilities to make it an optimal technology solution for delivery, guiding and filming equipment. Thanks to its outstanding maneuverability, the platform can also be used for service robots that can operate both indoors and outdoors.

MobED can be used as a mobility device for the elderly or the disabled when the platform is sufficiently increased for people to mount it. It can also be used as a stroller or leisure vehicle. Hyundai Motor Group will be at CES 2022, Jan. 5-8, 2022. At the event, Hyundai Motor will present its future vision with robotics. The MobED will also be on display at Hyundai Motor’s booth.

Kontakter

Bilder

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din epostadresse under for å få de nyeste sakene fra news aktuell GmbH på epost fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Animals' Angels: An ordeal that ends on a plate in a tourist resort: Live transports of calves to the Canary Islands10.8.2022 08:39:34 CEST | Press release

Every week, cattle are shipped to the Canary Islands under unacceptable conditions. These transports are extremely long. The animals stand on the truck for even more than 100 hours non-stop. Now, in summer, sweltering heat must be added as well as poor water supply, no or too little food, bedding of excrements and urine, lack of space, and an acrid ammonia smell. Once on the islands, the animals, only a few months old, await death in the slaughterhouse. A trade that is enhanced by subsidies and slaughter premiums.

Grünenthal to license osteoarthritis pain treatment to Shionogi in Japan in deal of up to > $ 500 million4.8.2022 09:00:00 CEST | Pressemelding

(Aachen, Germany) Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal’s investigational medicine Resiniferatoxin (“RTX”). Shionogi obtained the exclusive rights to commercialise Grünenthal’s asset in Japan for pain associated with osteoarthritis of the knee. RTX is currently in Phase III of clinical development for the treatment of patients with moderate to severe pain associated with knee osteoarthritis. Osteoarthritis, a progressive and often painful joint disease, is an indication with high unmet medical need. If approved, RTX could become a well-tolerated, non-opioid therapy option for patients, providing long-lasting pain relief and functional improvement of the affected knee joints. Under the terms of the agreement, Shionogi will obtain the exclusive commercialisation rights for RTX in Japan for a total consideration of up to $ 525 million plus additional sales based payments. Thereof, Shionogi will pay $ 75 million upon signat

Make some noise for endangered species: Krombacher and Wacken Open Air present the "Growling Creatures" – the first metal band consisting of endangered animals1.8.2022 11:14:47 CEST | Pressemelding

(Krombach, Germany): What do grey seals, cuckoos, and lynx have in common? They are all rare, European native species whose survival is threatened, and they are part of the "Growling Creatures" - the first metal band consisting of endangered animals. Presented by Krombacher and the legendary metal festival Wacken Open Air (W:O:A), this summer the Growling Creatures are drawing attention to their threat and are making some noise for endangered species. "With Krombacher, we have long been committed to domestic and international species protection projects," says Peter Lemm, Head of Communications of the Krombacher brewery. "As a new partner of the Wacken Open Air, it was important for us to create an authentic connection between our sustainable commitment and entertainment with a twinkle in the eye. The Growling Creatures represent exactly this - as musical newcomers of the year, they deliver the best metal sound for the good cause." Animalistic Metal Sound On their mini-EP “Growling Cre

Avsender: R-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories19.7.2022 08:36:55 CEST | Press release

(Darmstadt, Germany): As a fully integrated solution, the new and completely automated RIDA®UNITY system combines sample extraction, PCR setup, real-time PCR and result evaluation in a common workflow. The biotechnology company R-Biopharm AG announced today that it has received the CE mark and will begin selling the new, fully automated RIDA®UNITY system for molecular detection of infectious diseases throughout Europe. "With the RIDA®UNITY system, R-Biopharm is purposefully taking the path from a provider of individual solutions to a system provider in the field of molecular diagnostics," stated Christian Dreher, CEO of R-Biopharm. "We are very happy to make this system solution available to all molecular biology laboratories throughout Europe." Unique combination of different tools The RIDA®UNITY system combines the various steps in the analysis of patient samples into an integrated workflow – nucleic acid extraction, PCR setup, subsequent real-time PCR and the evaluation of the resul

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom